Art

J-GLOBAL ID：201902286608859097   Reference number：19A2410691

Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer

非小細胞肺癌に対する免疫療法を含む分子機構と標的療法【JST・京大機械翻訳】

Author (3)： Nagano Tatsuya ( Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Tachihara Motoko ( Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Nishimura Yoshihiro ( Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan)
Material： Current Cancer Drug Targets
Volume： 19  Issue： 8  Page： 595-630  Publication year： 2019 
JST Material Number： W3571A  ISSN： 1568-0096  Document type： Article
Article type： 文献レビュー  Country of issue： Unknown (ARE)  Language： ENGLISH (EN)

Abstract/Point： Lung cancer is the leading cau...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2410691&from=J-GLOBAL&jstjournalNo=W3571A") }}

Thesaurus term： human ,  combination therapy ,  *molecular target therapy ,  tumor immunity ,  *lung tumor ,  tumor cell ,  *Immunotherapy ,  therapy ,  *non-small cell lung cancer ,  antibody ,  Mutation ,  antitumor drug ,  oncogene
Semi thesaurus term： チェックポイント ,  ベバシズマブ , 【Automatic Indexing@JST】

Author keywords (8)： Non-small cell lung cancer ,  EGFR ,  ALK ,  ROS-1 ,  BRAF ,  RET ,  VEGF ,  Immune checkpoint inhibitor.

JST classification (2)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Gene expression  (EC02040Q)

Terms in the title (4)： 非小細胞肺癌 ,  免疫療法 ,  分子 ,  標的療法